Cervical sample collection
Pap tests have been used since the 1950s to screen cervical cancer with success, but they have also presented many limitations. Developed in the 1990s, liquid-based cytology (LBC) today brings improvements to laboratories, doctors and patients—in every step of the process, from collection to results.1
Why a liquid-based Pap test? »
BD Onclarity? HPV Assay offers genotyping for HPV primary screening, co-testing, and cytology primary with ASCUS reflex screening paradigms.
The BD SurePath liquid-based Pap Test is the liquid-based cytology test from BD. Offering proprietary features and benefits, the test provides advantages over conventional Pap smears and other LBC tests.
- Nance KV. Evolution of Pap testing at a community hospital: a ten year experience. Diagn Cytopathol. 2007:35(3):148-153.